Gini F. Fleming, Katherine Kurnit, Meredith Pelster, Pamela N. Munster, Raymond Couric Wadlow, Shigehiro Koganemaru, Chiyoe Kitagawa, Takako Eguchi Nakajima, Yuta Maruki, Ruth Perets, Akosua Badu-Nkansah, Martha Elizabeth Blaney, Manal Mehibel, Pin Li, Marjilla Seddiq, Anna Shurshalina, Omar N. Al Yacoub, Michael Charles Burns, Shigehisa Kitano. "Phase 1 basket study of telisotuzumab adizutecan (Temab-A, ABBV-400), a c-Met protein–targeting antibody-drug conjugate: Results from patients with platinum-resistant ovarian/primary peritoneal/fallopian tube cancer (PROC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5514